© 2021 MJH Life Sciences and HCPLive - Clinical news for connected physicians. All rights reserved.
© 2021 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
August 17, 2010
This year in the US, the American Cancer Society estimates that lung cancer will kill more people than breast, prostate, colon, liver, and kidney cancers combined, making it the leading cause of cancer death
August 16, 2010
News items reported in this issue:
1) 186-Gene Signature in Cancer Stem Cells Predicts Recurrence
2) National Prostate Cancer Coalition Commences Clinical Trial
3) Concomitant High-Dose Radiation Therapy Plus Cetuximab Improves
Locoregional Control and Reduces Mortality, with No Increase in
Radiation Therapyâ€“Associated Toxicity in Patients with Advanced
Squamous-Cell Carcinoma of the Head and Neck
4) STAT3 Pathway Inhibitor (Degrasyn) Drug Class Shows Promise in the
Treatment of Malignant Brain Tumors
Analysis of molecular genetic markers in biological fluids has often been proposed as a potential tool for cancer diagnosis. Markers are needed for lung cancer in particular because the disease is notorious for presenting late in its course.
New pancreatic cancer vaccine findings were presented at the 2007 Gastrointestinal Cancers Symposium, held January 19-21 in Orlando,